← Back to news

Markets

Fox Revenue Rises on Higher Ad Sales

Y

Wingstop (WING) Fell Amid a Reduction in Sales Momentum

Y

Inspire Medical Systems (INSP) Dropped After Lowering Its Financial Guidance

Y

Stocks Are Up—But Maybe Not Your Stocks

Y

Baron Discovery Fund Trimmed PAR Technology Corporation (PAR) Amid Macroeconomic Headwinds

Y

S&P 500 Steady on Mixed Tech Earnings, Fed Cautions and Expected Trump–Xi Meeting

I

Karman Holdings (KRMN) is Benefiting From Increased Defense Spending

Y

Stocks dip as investors mull Trump-Xi deal, cautious BOJ dents yen

Y

PG&E (PCG) Unveils $73 Billion Capital Spending Plan After a Steady Q3

Y

Baron Discovery Fund Expects Strong Growth and Margin Expansion for Mercury Systems (MRCY)

Y

First look: XPO Q3 earnings

Y

Shake Shack Sales Climb in Third Quarter

Y

Bristol Myers beats quarterly revenue estimates on strong Opdivo sales

Y

Biogen Cuts Full-Year Earnings Guidance, Despite Third-Quarter Profit Rise

Y

Don't Be A Seller: This CLO Fund Is Trading At A 2020 Crisis Price - OXLC

S

Bristol Myers Squibb Stock Rises After Solid Earnings. But These Problems Remain.

Y

Morning Bid: Hesitation about 'foregone conclusions'

Y

It's 'Going to Be Like a Shockwave' When Tesla's AI Innovations Hit. Should You Buy TSLA Stock First?

Y

I Was Right About Inflation - And It's About To Change Everything

S

40% of US adults admit to keeping a financial secret from their partner — how to tell if your spouse is hiding assets

Y

Unresolved: Why Big Tech, the Fed, and Trade Talks Provide Wall Street With Little Clarity

Y

Shell Tops Profit Estimates on Higher Output and Strong Trading

Y

Estee Lauder Swings to Profit, Backs Fiscal 2026 Revenue Growth View

Y

Analyst Report: Fiserv, Inc.

Y

Analyst Report: Cognizant Tech Solus Corp

Y

Analyst Report: Alcoa Corp

Y

Yen Drops After Bank of Japan Holds Rates Steady and Hopes Dim for Further Fed Cut

Y

Europe's Central Bank leaves key interest rate unchanged as businesses weather US tariffs

Y

Eli Lilly raises forecasts on surging demand for weight-loss drugs

Y

Roark Capital explores sale of Nothing Bundt Cakes

Y

DeFi Set to Challenge TradFi With $2T in Tokenized Assets by 2028: Standard Chartered

Y

HBAR Price Up 7%: Here’s Why Hedera Is Defying Crypto Crash

Y

Lilly hikes revenue forecasts on booming obesity drug sales

Y

Bristol Myers Squibb Profit Soars, Raises Revenue Guidance

Y

Americans in their 30s, 40s are getting richer faster than boomers — here’s how they’re outpacing their parents

Y

Is There a Future for Wolfspeed?

Y

Hong Kong Hits the Breaks on Crypto Treasury Firms—Premium Could Disappear ‘In a Day’ Warns Regulator

Y

Solex Energy signs MoU with ISC Konstanz for solar cell production

Y

Dogecoin Is Down 36%. Should You Buy the Dip?

Y

Mali annuls 90-plus mining exploration permits amid legal changes

Y

Remy Cointreau Cuts Outlook as Challenges in China, U.S. Persist

Y

The Fed Could Be On The Verge Of Unleashing A Major Market Shift

S

Daily Spotlight: Fed Cuts Rates for a Second Time in 2025

Y

Technical Assessment: Bullish in the Intermediate-Term

Y

Market Digest: AMT, CTSH, DECK, EA, FI, AA

Y

Helping Your Adult Kids With Money Could 'Wreck' Your Retirement

Y

Adobe Systems Bear Put Spread Could Return 233% in this Down Move

Y

Washington’s $200 Million Move to Rebuild America’s Rare Earth Supply Chain

Y

C.H. Robinson’s AI strategy boosts 2026 financial forecast

Y

Eli Lilly raises full-year forecast, as weight-loss drugs demand drives third-quarter beat

Y